Loss or reduction of E-cadherin expression appears in many advanced, poorly differentiated, and invasive human tumors, suggesting that reducing cell-cell contacts mediated by E-cadherin promotes tumor progression and metastasis [12,13]. Here, CDH1 is linked to neoplasm.